AI assistant
Sending…
RESMED INC — Director's Dealing 2025
Nov 26, 2025
30071_dirs_2025-11-26_9df310d2-c413-43b5-964d-22405bc48cb8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2025-11-24
Reporting Person: Farrell Michael J. (Director, Chairman and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-11-24 | ResMed Common Stock Options | $250.52 | A | 33288 | Acquired | 2032-11-11 | ResMed Common Stock (33288) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 466223 | Direct |
Footnotes
F1: Represents the date on which options first become exercisable. The options vest in three equal annual installments commencing on November 11, 2026.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29